Skip to main content
. 2010 Sep 8;2010(9):CD008418. doi: 10.1002/14651858.CD008418.pub2

4.

4

In patients on short‐acting beta2‐agonists, 117 people out of 1000 had exacerbations requiring oral corticosteroids over 30 weeks, compared to 101 (95% CI 93 to 108) out of 1000 for patients on formoterol as‐needed.